Fosamax Side Effects Lawsuits Rise as New FDA Warnings Are Expected

California Fosamax Side Effects Attorney
FDA expected to create new warning labels for Fosamax, similar drugs.

In response to the growing number of Fosamax side effects lawsuits, the Food and Drug Administration is expected to issue new warnings for the drug.

Lawsuits have already been filed in several states against Merck, the manufacturer of Fosamax, alleging that the drug caused osteoporosis of the jaw in some female patients. Researchers at the University of Colorado have suggested that long-term use of Fosamax and similar bone-density drugs such as Actonel and Boniva can significantly weaken bone structures, leading to an increased risk of developing osteoporosis and a greater propensity for serious bone fractures or breaks.

The potential for developing a condition known as osteonecrosis, a deadening of the jaw bone following an infection, is also believed to be higher among women who use Fosamax and other bone-density medications.

The US Drug Watchdog, a consumer advocacy group, has issued a nationwide call urging women who have used or are using Fosamax and similar drugs to contact their organization with details about their injuries. The group is particularly interested in those women who have used bone-density drugs within the last five years and experienced a serious fracture or break to their femur. According to a press release issued to the San Francisco Chronicle, the organization’s primary goal is to connect women who have suffered injuries after using Fosamax, Boniva or Actonel with a personal injury lawyer experienced in handling these types of claims.

Numerous lawsuits are still pending against Merck, which are scheduled to go to trial beginning in February 2012. The drug-maker has previously claimed victory in four of five bellweather trials which involved lawsuits claiming injuries stemming specifically from osteonecrosis allegations. At least one of the verdicts is likely to be appealed by the plaintiffs’ attorneys.

In September 2011, an advisory panel recommended new warning labels for Fosamax and similar drugs. These warnings are expected to come later this month, with the FDA advising Fosamax and other bone-density drug users of the potential for an increased risk of developing osteonecrosis and experiencing serious bone fractures. It is believed that the outcome of the next wave of product liability trials may determine whether the FDA decides to issue a full recall of Fosamax and its counterparts.

If you or a loved one has experienced a deterioration of the jawbone, broken bones or other serious injuries after using Fosamax or another bone-density drug, you need to contact a qualified California personal injury attorney today. The law firm of Nadrich & Cohen has investigated claims from women across the country regarding allegations of injuries caused by Fosamax side effects and we are dedicated to helping you get the compensation you’re entitled to.

Contact us at 1-800-722-0765 to find out how we can help. We offer a free initial case evaluation and we charge no fee unless we recover a money judgment on your behalf. Call us today to get expert legal representation for your Fosamax side effects injury lawsuit.

Do I Have A Case?

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.


What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.


Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

March 20, 2019

Valsartan Dangers: 3 Things You Should Know

Several drugs containing Valsartan have been  recalled in the U.S. because they contain impurities which may be cancer risks. You may be eligible for financial compensation if you took a drug containing Valsartan and have been diagnosed with cancer.

March 15, 2019

Expert Testifies Before House Subcommittee Regarding Talc Use And Ovarian Cancer Link

A United States House of Representatives subcommittee, on March 12th, 2019, looked into whether they should give the Food and Drug Administration (FDA) the power to more strictly regulate cosmetics, including talcum powder and products containing talc.


We are Personal Injury Lawyers representing accident victims throughout California.
For 30 years, the law firm of Nadrich & Cohen, LLP has helped injury victims
obtain the compensation they deserve.